Details for New Drug Application (NDA): 087563
✉ Email this page to a colleague
The generic ingredient in QUIBRON-T/SR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 087563
Tradename: | QUIBRON-T/SR |
Applicant: | Monarch Pharms |
Ingredient: | theophylline |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 087563
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 300MG | ||||
Approval Date: | Jun 21, 1983 | TE: | RLD: | No |
Expired US Patents for NDA 087563
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Monarch Pharms | QUIBRON-T/SR | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087563-001 | Jun 21, 1983 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription